We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
23 hedge funds and large institutions have $1.94M invested in CASI Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
113% more capital invested
Capital invested by funds: $910K → $1.94M (+$1.03M)
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
15% more funds holding
Funds holding: 20 → 23 (+3)
0.74% more ownership
Funds ownership: 1.89% → 2.63% (+0.74%)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Holders
23
Holders Change
+3
Holders Change %
+15%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
3
Reduced
4
Closed
4
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
+$1K
Top Buyers
| 1 |
VA
VR Adviser
New York
|
+$347K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$35.2K |
| 3 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$25.6K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$21.4K |
| 5 |
Renaissance Technologies
New York
|
+$12.4K |
